A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

Clinical trial NCT07252375 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07252375
Sponsor: Fujian Cancer Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma (NPC)CTIT-Chemotherapy Induced Thrombocytopenia

Start date: 2025-11-30
Primary completion: 2028-05-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.